21st July 2011 Content supplied by: Pro-Lab Diagnostics
Pro-Lab Diagnostics Releases C. difficile GDH Immunoassay
Pro-Lab Diagnostics has launched an immunoassay for rapid and accurate screening of patients with suspected Clostridium difficile infection. The Prolisa™ C. difficile GDH (glutamate dehydrogenase) EIA achieves excellent sensitivity and specificity thanks to a mouse monoclonal GDH antibody, and offers a high negative predictive value to quickly and easily rule out C.difficile infection.
Many recent studies have demonstrated that C. difficile infection can be identified more efficiently and economically by initially screening for GDH, rather than by testing for toxins alone. Mark Reed, General Manager of Pro-Lab Diagnostics, explained: “Screening for GDH as a marker present in toxigenic and non-toxigenic strains of C. difficile, followed by tests for toxin A or toxin B on GDH-positive samples, is an easy, quick and cost-effective way to test for C. difficile infection, as several UK customers are already finding.”
Supported by Pro-Lab Diagnostics' team of experts, the Prolisa C. difficile GDH EIA is a manual immunoassay, available in a 96-well test size, that has also been optimized and validated for the most widely used automated platforms. Reagents are supplied in larger volumes as standard, to accommodate automated systems and provide more flexibility, and are also available separately, with comprehensive lot-to-lot compatibility.
Date Published: 21st July 2011
Source article link: View